Home / Inspections / 990058

FDA Inspection 990058 — Hikma Pharmaceuticals USA Inc.

Hikma Pharmaceuticals USA Inc. — FEI 3012279857

The FDA completed an inspection of Hikma Pharmaceuticals USA Inc. on October 13, 2016 in Bedford, OH. The inspection was classified NAI (No Action Indicated — no objectionable conditions were found). Product area: Drugs.

Inspection Details

Classification
No Action Indicated (NAI) (NAI)
End Date
October 13, 2016
Fiscal Year
2017
Product Type
Drugs
Project Area
Drug Quality Assurance
Location
Bedford, OH (United States)

Facility

Other inspections at this facility

  • 1220071 (VAI Fri Sep 29 2023 00:00:00 GMT+0000 (Coordinated Universal Time))
  • 1194565 (VAI Thu Dec 15 2022 00:00:00 GMT+0000 (Coordinated Universal Time))
  • 1161837 (VAI Mon Feb 07 2022 00:00:00 GMT+0000 (Coordinated Universal Time))
  • 1117006 (VAI Fri Jan 31 2020 00:00:00 GMT+0000 (Coordinated Universal Time))

Recent compliance actions

  • Injunction (311) (Thu Jan 31 2013 00:00:00 GMT+0000 (Coordinated Universal Time))

FDA data resources